Promising treatment gives fresh hope to patients with rare, deadly cancer
There is fresh hope for patients with a rare, deadly form of cancer most commonly found in younger adults.
Some Albertans are part of the fight for approval of a promising new treatment.
Golfing and planning visits with family and friends were not possible while Jennifer Nielsen was going through chemotherapy.
But that changed when she started a new treatment in September.
"You don't have those up-and-down swings with this drug, which is mentally as well as physically amazing," Nielsen said.
That drug—Pemigatinib, brand name Pemazyre—could become more widely available in Canada.
"I'm happy to see the government moving forward," Nielsen said.
It treats cholangiocarcinoma—bile duct cancer.
The Canadian Drug Agency previously decided not to recommend Pemazyre but is reconsidering and wants to hear from patients and doctors by Dec. 13.
"It gives them hope, and that's what they like about Pemazyre—it gives them hope," said Brenda Clayton with Cholangio-Hepatocellular Carcinoma Canada.
Clayton's family has been fighting for people with this rare cancer since her oldest daughter died of the disease after her first treatment ended and no other options were available.
"It's one of the cancers that doesn't have a first-line targeted therapy, and so, really, that has to change," she said.
Patients who need another option but can't get it survive an average of five months.
After CTV did a story with a new dad in need of another treatment, Alberta agreed to cover the roughly $15,000 a month of Pemazyre on a case-by-case basis.
That's how Nielsen got approval.
She hopes sharing her experience will give many more people the same chance.
"There is work being done in Europe and the United States with this, and Canada needs to get along the same lines and access so that patients have options," she said.
"You need something in the future for your hope."
Advocates expect the Canadian Drug Agency will make its decision on the treatment in March.
Anyone who wants to share their story with bile duct cancer can reach out to Clayton’s advocacy group.
CTVNews.ca Top Stories
'Canada will be absolutely fine': Justin Trudeau, his ministers and Pierre Poilievre congratulate Donald Trump
Canadian Prime Minister Justin Trudeau and members of his cabinet congratulated Donald Trump Wednesday morning on his second United States presidential election win, amid questions about how the federal government intends to navigate a second term.
What Donald Trump's election victory could mean for Canada
Following president-elect Donald Trump's decisive election victory, there are sure to be significant knock-on effects for Canada. Here's a look at the different areas in which a second Trump presidency may affect Canadians.
Kamala Harris concedes: Here's what she said in her speech
Democratic Vice-President Kamala Harris conceded the U.S. election to Republican Donald Trump Wednesday afternoon, telling her supporters that her 'heart is full.'
Canada orders wind up of TikTok's Canadian business, app access to continue
The federal government is ordering the dissolution of TikTok's Canadian business after a national security review of the Chinese company behind the social media platform, but stopped short of ordering people to stay off the app.
Newfoundland hockey player suspended, banned from local arena after off-ice fight with fan
A combination of a thrown stick and thrown punches have given a senior hockey player in Newfoundland a three-game suspension and an indefinite ban from one of his league's six arenas.
Controversial Australian Olympic breakdancer 'Raygun' retires from competition
Australian breaker Rachael Gunn has told a Sydney radio station that she plans to retire from competition just three months after her unconventional routine at the Paris Olympics led to her being ridiculed and spawned conspiracy theories about how she qualified for the Games.
Sleepy during the day? You may be at higher risk for a pre-dementia syndrome, study finds
If you find yourself sleepy during your daily activities in your older age, you may need to consider it more than an inconvenience — since the fatigue may indicate you’re at higher risk for developing a condition that can lead to dementia, a new study has found.
Kamala Harris made a historic dash for the White House. Here's why she fell short.
"Sometimes the fight takes a while. That doesn't mean we won't win," U.S. Vice-President Kamala Harris said on Wednesday in her concession speech.
Who won the popular vote? U.S. election vote totals from the past 40 years
Donald Trump won the U.S. presidency on Tuesday, and as of Wednesday morning, was also ahead in the popular vote. Historically, though, the candidate with the most votes hasn’t always won the contest.